PharmaVoice Logo

Healthcare Leaders Hub

AriBio Reports P-III (POLARIS-AD) Data of Oral AR1001 for Early Alzheimer’s Disease

PharmaShots

AriBio Reports P-III (POLARIS-AD) Data of Oral AR1001 for Early Alzheimer’s Disease

Shots: AriBio has reported data from the P-III (POLARIS-AD) trial of oral AR1001 (30mg) in early Alzheimer’s disease, with the 1EP of change in CDR-SB at wk. 52 evaluated in two prespecified populations (Overall & Monotherapy) The trial met its primary efficacy objective in the Monotherapy population (n=604; pts not on an AChE inhibitor or… The post AriBio Reports P-III (POLARIS-AD) Data of Oral AR1001 for Early Alzheimer’s Disease appeared first on PharmaShots.

Read Full Article
Lantheus Reports P-III Data of TAUKLARIFY (Florquinitau F-18) PET Imaging in Early Alzheimer’s Disease

PharmaShots

Lantheus Reports P-III Data of TAUKLARIFY (Florquinitau F-18) PET Imaging in Early Alzheimer’s Disease

Shots: Lantheus has presented data from two pivotal P-III studies of TAUKLARIFY (florquinitau F-18 injection; MK-6240) PET imaging, used in adults with cognitive impairment being evaluated for Alzheimer’s disease to identify pts with neurofibrillary tangle (NFT) pathology, at CTAD 2026 Across 617 scans, all 5 independent readers in each study met the prespecified co-primary sensitivity… The post Lantheus Reports P-III Data of TAUKLARIFY (Florquinitau F-18) PET Imaging in Early Alzheimer’s Disease appeared first on PharmaShots.

Read Full Article
The US FDA Clears Medtronic’s Hugo RAS System for General Surgery Procedures

PharmaShots

The US FDA Clears Medtronic’s Hugo RAS System for General Surgery Procedures

Shots: The US FDA has cleared Medtronic’s Hugo robotic-assisted surgery (RAS) system for use in general surgery procedures, via an expanded 510(k) The clearance covers all upper abdominal general surgical procedures, incl. cholecystectomy, Roux-en-Y gastric bypass, ventral hernia & small bowel resection, plus lower abdominal inguinal hernia repair & appendectomy; together these account for ~3.5M… The post The US FDA Clears Medtronic’s Hugo RAS System for General Surgery Procedures appeared first on PharmaShots.

Read Full Article
The US FDA Clears MiniMed Fit, a Tubeless Insulin Pump with Up to Seven-Day Wear

PharmaShots

The US FDA Clears MiniMed Fit, a Tubeless Insulin Pump with Up to Seven-Day Wear

Shots: The US FDA has cleared MiniMed Fit, the company’s first tubeless insulin pump, for people with T1D & T2D aged ≥7yrs., combining up to 7-day wear, a 300-unit insulin capacity, app control & SmartGuard technology The system automatically adjusts insulin delivery and can deliver correction doses every 5min., with Meal Detection technology to deliver… The post The US FDA Clears MiniMed Fit, a Tubeless Insulin Pump with Up to Seven-Day Wear appeared first on PharmaShots.

Read Full Article
The US FDA Grants De Novo Authorization to Roche’s cobas pro i 601 Platform with the Ionify Gabapentin Assay

PharmaShots

The US FDA Grants De Novo Authorization to Roche’s cobas pro i 601 Platform with the Ionify Gabapentin Assay

Shots: The US FDA has granted De Novo authorization to Roche’s cobas pro i 601 platform with the Ionify Gabapentin assay, part of its cobas Mass Spec solution, bringing automated mass spectrometry into routine clinical laboratories for therapeutic drug monitoring The Ionify Gabapentin assay adds a TDM application to Roche’s US mass spectrometry menu, which… The post The US FDA Grants De Novo Authorization to Roche’s cobas pro i 601 Platform with the Ionify Gabapentin Assay appeared first on PharmaShots.

Read Full Article

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

PharmaShots

Nov 17, 2026, 10:23 PM

AriBio Reports P-III (POLARIS-AD) Data of Oral AR1001 for Early Alzheimer’s Disease

Shots: AriBio has reported data from the P-III (POLARIS-AD) trial of oral AR1001 (30mg) in early Alzheimer’s disease, with the 1EP of change in CDR-SB at wk. 52 evaluated in two prespecified populations (Overall & Monotherapy) The trial met its primary efficacy objective in the Monotherapy population (n=604; pts not on an AChE inhibitor or… The post AriBio Reports P-III (POLARIS-AD) Data of Oral AR1001 for Early Alzheimer’s Disease appeared first on PharmaShots.

PharmaShots

Nov 17, 2026, 10:22 PM

Lantheus Reports P-III Data of TAUKLARIFY (Florquinitau F-18) PET Imaging in Early Alzheimer’s Disease

Shots: Lantheus has presented data from two pivotal P-III studies of TAUKLARIFY (florquinitau F-18 injection; MK-6240) PET imaging, used in adults with cognitive impairment being evaluated for Alzheimer’s disease to identify pts with neurofibrillary tangle (NFT) pathology, at CTAD 2026 Across 617 scans, all 5 independent readers in each study met the prespecified co-primary sensitivity… The post Lantheus Reports P-III Data of TAUKLARIFY (Florquinitau F-18) PET Imaging in Early Alzheimer’s Disease appeared first on PharmaShots.

PharmaShots

Nov 17, 2026, 10:21 PM

The US FDA Clears Medtronic’s Hugo RAS System for General Surgery Procedures

Shots: The US FDA has cleared Medtronic’s Hugo robotic-assisted surgery (RAS) system for use in general surgery procedures, via an expanded 510(k) The clearance covers all upper abdominal general surgical procedures, incl. cholecystectomy, Roux-en-Y gastric bypass, ventral hernia & small bowel resection, plus lower abdominal inguinal hernia repair & appendectomy; together these account for ~3.5M… The post The US FDA Clears Medtronic’s Hugo RAS System for General Surgery Procedures appeared first on PharmaShots.

PharmaShots

Nov 17, 2026, 10:19 PM

The US FDA Clears MiniMed Fit, a Tubeless Insulin Pump with Up to Seven-Day Wear

Shots: The US FDA has cleared MiniMed Fit, the company’s first tubeless insulin pump, for people with T1D & T2D aged ≥7yrs., combining up to 7-day wear, a 300-unit insulin capacity, app control & SmartGuard technology The system automatically adjusts insulin delivery and can deliver correction doses every 5min., with Meal Detection technology to deliver… The post The US FDA Clears MiniMed Fit, a Tubeless Insulin Pump with Up to Seven-Day Wear appeared first on PharmaShots.

PharmaShots

Nov 17, 2026, 9:53 PM

The US FDA Grants De Novo Authorization to Roche’s cobas pro i 601 Platform with the Ionify Gabapentin Assay

Shots: The US FDA has granted De Novo authorization to Roche’s cobas pro i 601 platform with the Ionify Gabapentin assay, part of its cobas Mass Spec solution, bringing automated mass spectrometry into routine clinical laboratories for therapeutic drug monitoring The Ionify Gabapentin assay adds a TDM application to Roche’s US mass spectrometry menu, which… The post The US FDA Grants De Novo Authorization to Roche’s cobas pro i 601 Platform with the Ionify Gabapentin Assay appeared first on PharmaShots.

PharmaShots

Nov 17, 2026, 9:51 PM

The US FDA Grants Accelerated Approval to GSK’s Nelkarmi (Neladalkib) for Previously Treated ALK-Positive NSCLC

Shots: The US FDA has granted accelerated approval to GSK’s Nelkarmi (neladalkib) for adults with locally advanced or metastatic ALK-positive NSCLC previously treated with alectinib as their only prior ALK TKI, or with ≥2 prior ALK TKIs and platinum-based chemotherapy Approval was based on the P-I/II (ALKOVE-1) trial: ORR was 49% (33/67) after alectinib alone… The post The US FDA Grants Accelerated Approval to GSK’s Nelkarmi (Neladalkib) for Previously Treated ALK-Positive NSCLC appeared first on PharmaShots.

News

Latest industry coverage

Google News

Nov 17, 2026, 10:15 PM

After battle with activist investor, Pacira BioSciences finds $1.7 billion deal gain from pain - The Business Journals

After battle with activist investor, Pacira BioSciences finds $1.7 billion deal gain from pain  The Business Journals

Google News

Nov 17, 2026, 10:06 PM

CPI | Teva Reaches Settlement With US States Over Generic Drug Price-Fixing - PYMNTS.com

CPI | Teva Reaches Settlement With US States Over Generic Drug Price-Fixing  PYMNTS.com

Google News

Nov 17, 2026, 9:37 PM

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)  Arrowhead Pharmaceuticals, Inc.

Google News

Nov 17, 2026, 9:22 PM

Made Scientific, Orca Bio Reach Long-Term Pact for Tregzi Manufacturing - Contract Pharma

Made Scientific, Orca Bio Reach Long-Term Pact for Tregzi Manufacturing  Contract Pharma

Google News

Nov 17, 2026, 9:06 PM

Centrix Pharma Solutions appoints Dr Nathalie Huther to lead business development and commercial strategy - Manufacturing Chemist

Centrix Pharma Solutions appoints Dr Nathalie Huther to lead business development and commercial strategy  Manufacturing Chemist

Google News

Nov 17, 2026, 8:31 PM

FDA Approves Cosentyx and Wilserdly | PharmExec - Pharmaceutical Executive

FDA Approves Cosentyx and Wilserdly | PharmExec  Pharmaceutical Executive

Google News

Nov 17, 2026, 7:58 PM

Blood pressure medication recalled nationwide because of possible metal contamination - TribLIVE.com

Blood pressure medication recalled nationwide because of possible metal contamination  TribLIVE.com

Google News

Nov 17, 2026, 7:55 PM

OXB, Aura to Partner on Phase III Development, Future Supply of Oncology Candidate - Contract Pharma

OXB, Aura to Partner on Phase III Development, Future Supply of Oncology Candidate  Contract Pharma

Google News

Nov 17, 2026, 7:51 PM

Recalled Blood Pressure Medicine May Contain Metal, Company Warns: What To Know - DailyVoice.com

Recalled Blood Pressure Medicine May Contain Metal, Company Warns: What To Know  DailyVoice.com

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer